R Judd Jessup Sells 4,023 Shares of CorVel (NASDAQ:CRVL) Stock

CorVel Corp. (NASDAQ:CRVL) Director R. Jessup sold 4,023 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $70.07, for a total value of $281,891.61. Following the completion of the transaction, the director directly owned 111,798 shares in the company, valued at $7,833,685.86. This trade represents a 3.47% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

R Judd Jessup also recently made the following trade(s):

• On Thursday, August 27th, R. Jessup sold 1,262 shares of CorVel stock. The stock was sold at an average price of $70.64, for a total transaction of $89,147.68.
• On Wednesday, August 26th, R. Jessup sold 1,562 shares of CorVel stock. The shares were sold at an average price of $70.71, for a total transaction of $110,449.02.

CorVel Stock Performance

Shares of CorVel stock opened at $68.23 on Friday. CorVel Corp. has a fifty-two week low of $44.83 and a fifty-two week high of $93.45. The company has a market capitalization of $3.48 billion, a P/E ratio of 30.32 and a beta of 0.97. The company has a fifty day moving average of $64.25 and a 200 day moving average of $58.99.

CorVel (NASDAQ:CRVL) last released its quarterly earnings data on Tuesday, August 4th. The business services provider reported $0.63 earnings per share for the quarter. The firm had revenue of $259.93 million during the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.72%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Weiss Ratings upgraded shares of CorVel from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has a consensus rating of “Hold”.

Institutional Investors Weigh In On CorVel

Hedge funds have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in CorVel by 0.7% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock valued at $1,640,000 after purchasing an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of CorVel by 0.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock valued at $1,636,000 after buying an additional 139 shares in the last quarter. MassMutual Private Wealth & Trust FSB lifted its holdings in shares of CorVel by 18.9% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,228 shares of the business services provider’s stock valued at $77,000 after acquiring an additional 195 shares during the last quarter. Benjamin Edwards Inc. lifted its holdings in shares of CorVel by 6.0% in the 4th quarter. Benjamin Edwards Inc. now owns 3,843 shares of the business services provider’s stock valued at $260,000 after acquiring an additional 218 shares during the last quarter. Finally, Rockefeller Capital Management L.P. grew its position in CorVel by 66.9% in the fourth quarter. Rockefeller Capital Management L.P. now owns 574 shares of the business services provider’s stock worth $39,000 after acquiring an additional 230 shares in the last quarter. Hedge funds and other institutional investors own 51.36% of the company’s stock.

About CorVel

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).